REFERENCES
[1] Gathiram, P., & Moodley, J. (2016). Pre-eclampsia: Its pathogenesis and pathophysiology. Cardiovascular Journal of Africa, 27(2), 71-78. doi:10.5830/cvja-2016-009
[2]​​ Preeclampsia & Eclampsia: Risk Factors, Signs & Symptoms, and Treatment. (n.d.). Retrieved from https://www.webmd.com/baby/guide/preeclampsia-eclampsia#1​
[3] Center for Devices and Radiological Health. (2016, August 1). Mobile Medical Applications - Examples of Mobile Apps For Which the FDA Will Exercise Enforcement Discretion. Retrieved from https://www.fda.gov/MedicalDevices/DigitalHealth/MobileMedicalApplications/ucm368744.htm
[4] Code of Federal Regulations. (2019, February 26). Retrieved from
[5] Code of Federal Regulations. (2019, February 26). Retrieved from
[6] CFR - Code of Federal Regulations Title 21. (2018, September 04). Retrieved from https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfCFR/CFRSearch.cfm
[7] Marko, K. I., Krapf, J. M., Meltzer, A. C., Oh, J., Ganju, N., Martinez, A. G., ... & Gaba, N. D. (2016). Testing the feasibility of remote patient monitoring in prenatal care using a mobile app and connected devices: a prospective observational trial. JMIR research protocols, 5(4).
[8] Kaser, B. A. (2006). Patent Application Recycling: How Continuations Impact Patent Quality & What the USPTO Is Doing About It. J. Pat. & Trademark Off. Soc'y, 88, 426.
[9] National Center for Health Statistics. (2017, March 31). Retrieved from https://www.cdc.gov/nchs/fastats/births.htm
[10] Fast Facts on U.S. Hospitals, 2019 | AHA. (2019, January). Retrieved from https://www.aha.org/statistics/fast-facts-us-hospitals
[11] Ananth, C. V., Keyes, K. M., & Wapner, R. J. (2013). Pre-eclampsia rates in the United States, 1980-2010: Age-period-cohort analysis. Bmj, 347(Nov07 15). doi:10.1136/bmj.f6564​